1-(4-chlorophenyl)-1H-1,2,4-triazole | 89894-21-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-(4-chlorophenyl)-1H-1,2,4-triazole
• 英文别名: 1-(4-Chlorophenyl)-1,2,4-triazole
• CAS: 89894-21-3
• 化学式: C₈H₆ClN₃
• 分子量: 179.609
• InChiKey: UMCFBXCOSUBKBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-chlorophenyl)-1H-1,2,4-triazole 在 N-溴代丁二酰亚胺(NBS) 、 过氧化苯甲酰 作用下， 以 四氯化碳 为溶剂， 反应 12.0h， 以53%的产率得到5-bromo-1-(4-chlorophenyl)-1H-1,2,4-triazole
  参考文献：
  名称：

  Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin Analogues

  摘要：

  A series of 1-aryl-5-(3',4',5'-trimethoxyphenyl) derivatives and their related 1-(3',4',5'-trimethoxyphenyl)5-aryl-1,2,4-triazoles, designed as cis-restricted combretastatin analogues, were synthesized and evaluated for antiproliferative activity, inhibitory effects on tubulin polymerization, cell cycle effects, and apoptosis induction. Their activity was greater than, or comparable with, that of the reference compound CA-4. Flow cytometry studies showed that HeLa and Jurkat cells treated with the most active compounds 4l and 4o were arrested in the G2/M phase of the cell cycle in a concentration dependent manner. This effect was accompanied by apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, activation of caspase-3, and PA RP cleavage. Compound 41 was also shown to have potential antivascular activity, since it induced endothelial cell shape change in vitro and disrupted the sprouting of endothelial cells in the chick aortic ring assay.

  DOI：

  10.1021/jm100245q
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 五氯化磷 、 三氯氧磷 作用下， 生成 1-(4-chlorophenyl)-1H-1,2,4-triazole
  参考文献：
  名称：

  Andreocci; Mannino, Gazzetta Chimica Italiana, 1899, vol. 29 II, p. 46

  摘要：

  DOI：

文献信息

• Efficient and recyclable copper-based MOF-catalyzed N-arylation of N-containing heterocycles with aryliodides
  作者：Zihao Li、Fei Meng、Jie Zhang、Jianwei Xie、Bin Dai

  DOI：10.1039/c6ob02068b

  日期：——

  Copper-based MOF-199 was used as an efficient heterogeneous catalyst to catalyze cross-coupling reactions between N-containing heterocycles and aryliodides with high yields.

  铜基 MOF-199 被用作一种高效的异相催化剂，可催化含 N 杂环与芳基碘化物之间的交叉偶联反应，且产率高。
• Electrophotocatalytic S _N Ar Reactions of Unactivated Aryl Fluorides at Ambient Temperature and Without Base
  作者：He Huang、Tristan H. Lambert

  DOI：10.1002/anie.201909983

  日期：2020.1.7

  The electrophotocatalytic SN Ar reaction of unactivated aryl fluorides at ambient temperature without strong base is demonstrated.

  证明了在室温下没有强碱的未活化芳基氟化物的电光催化SN Ar反应。
• [EN] MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES MULTI-CIBLE POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
  申请人：UNIV PENNSYLVANIA

  公开号：WO2018048969A1

  公开（公告）日：2018-03-15

  The present disclosure provides methods of treating neurodegenerative diseases, peripheral inflammatory conditions, cancers, or parasitic diseases in a subject, comprising administering to the subject a compound of Formula (I), (II), (III), and/or (IV):(I), (II), (III), (IV) or a pharmaceutically acceptable salt thereof, wherein X. R1-R8, R21-R28. R31-R38, and R41-R48 are as defined herein.

  本公开提供了治疗受试者的神经退行性疾病、外周炎症性疾病、癌症或寄生虫病的方法，包括向受试者施用式(I)、(II)、(III)和/或(IV)的化合物：(I)、(II)、(III)、(IV)或其药学上可接受的盐，其中X、R1-R8、R21-R28、R31-R38和R41-R48如本文所定义。
• Phosphorescent Platinum(II) Complexes Based on C^∧C* Cyclometalating Aryltriazol-5-ylidenes
  作者：Mario Tenne、Stefan Metz、Ingo Münster、Gerhard Wagenblast、Thomas Strassner

  DOI：10.1021/om4004576

  日期：2013.11.11

  solid-state structures of seven complexes could be obtained by single-crystal X-ray diffraction. According to absorption and emission spectra, the complexes reveal interesting photophysical properties with strong emissions in the blue region of the visible spectrum at room temperature, which are sensitive to the donor and acceptor properties of the substituents at the cyclometalating ligand.

  两个系列的杂铂（II）卡宾的类型的compexes [PT（C ∧ C *）（O ∧ O）]（O ∧ O =乙酰丙酮）以C ∧ C *环金属化4-苯基-1,2,4-制备了三唑-5-亚烷基以及1-苯基-1,2,4-三唑-5-亚烷基配体。各种取代基在苯环的4位上的作用（4-苯基三唑：H，Cl，OCH 3，NO 2； 1-苯基三唑：H，Cl，OCH 3，CH 3）进行了研究。通过将相应的芳基1,2,4-三唑与碘甲烷季铵化获得配体前体。通过三唑鎓前体经由银（I）碳烯，二氯（1,5-环辛二烯）铂（II）的金属转移，环金属化反应以及最后添加乙酰丙酮化物的反应顺序来合成配合物。所有配合物均已通过标准技术进行了表征，例如1 H NMR，1313 C NMR和元素分析。另外，可以通过单晶X射线衍射获得七个配合物的固态结构。根据吸收和发射光谱，该络合物在室温下在可见光谱的蓝色区域中显示出有趣的光物理性质和强发
• Synergistic catalysis for light-driven proton reduction using a polyoxometalate-based Cu–Ni heterometallic–organic framework
  作者：Wenlong Sun、Cheng He、Tao Liu、Chunying Duan

  DOI：10.1039/c8cc09285k

  日期：——

  Cu–Ni–POM employing bimetallic Cu–Ni and POM, which allows a concerted catalysis mechanism, hydrogen evolution reaction exhibited higher activity.

  Cu-Ni-POM采用双金属Cu-Ni和POM，可以实现协同催化机制，氢析出反应表现出更高的活性。